Jiang Zhong Pharmaceutical Co Ltd
SSE:600750

Watchlist Manager
Jiang Zhong Pharmaceutical Co Ltd Logo
Jiang Zhong Pharmaceutical Co Ltd
SSE:600750
Watchlist
Price: 21.99 CNY 0.96% Market Closed
Market Cap: 13.8B CNY
Have any thoughts about
Jiang Zhong Pharmaceutical Co Ltd?
Write Note
Jiang Zhong Pharmaceutical Co Ltd
/
Balance Sheet
/
Other Long-Term Assets

Jiang Zhong Pharmaceutical Co Ltd
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jiang Zhong Pharmaceutical Co Ltd
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Jiang Zhong Pharmaceutical Co Ltd
SSE:600750
Other Long-Term Assets
¥62.1m
CAGR 3-Years
-15%
CAGR 5-Years
9%
CAGR 10-Years
7%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Other Long-Term Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Other Long-Term Assets
¥215.7m
CAGR 3-Years
-19%
CAGR 5-Years
10%
CAGR 10-Years
9%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Other Long-Term Assets
¥702.3m
CAGR 3-Years
24%
CAGR 5-Years
25%
CAGR 10-Years
33%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Other Long-Term Assets
¥928.6m
CAGR 3-Years
15%
CAGR 5-Years
12%
CAGR 10-Years
19%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Other Long-Term Assets
¥84.9m
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Jiang Zhong Pharmaceutical Co Ltd
Glance View

Market Cap
13.8B CNY
Industry
Pharmaceuticals

Jiang Zhong Pharmaceutical Co Ltd. has etched its mark in the bustling landscape of China's pharmaceutical industry by embracing a strategic blend of traditional Chinese medicine (TCM) and modern medical practices. Founded in 1969 and headquartered in Wuhan, this company has steadily navigated the dynamic tides of China's healthcare sector. Jiang Zhong specializes in producing and marketing a wide array of TCM products, which are deeply rooted in ancient Chinese medical philosophies and practices. These offerings cater to various health needs, including gastrointestinal management, respiratory treatments, and nutritional supplements, which resonate well with China's rich cultural heritage of natural health solutions. The company's commitment to quality and efficacy has allowed it to carve out a substantial market niche where tradition meets innovation. Making money for Jiang Zhong Pharmaceutical Co Ltd. revolves around its robust distribution networks and strong brand presence across key domestic markets. The company has invested in extensive research and development initiatives to ensure its product line remains relevant and effective in addressing modern health challenges, alongside its traditional product offerings. By leveraging a diverse marketing strategy that includes partnerships with healthcare institutions, direct consumer promotions, and digital platforms, Jiang Zhong successfully taps into both local and international markets. Additionally, the company enhances its profitability through economies of scale and strategic cost management, allowing it to maintain competitive pricing while achieving substantial revenue growth. This balanced approach of blending tradition with innovation continues to fortify Jiang Zhong Pharmaceutical's position as a respected entity in both TCM and broader pharmaceutical realms.

Intrinsic Value
26.49 CNY
Undervaluation 17%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Jiang Zhong Pharmaceutical Co Ltd's Other Long-Term Assets?
Other Long-Term Assets
62.1m CNY

Based on the financial report for Sep 30, 2024, Jiang Zhong Pharmaceutical Co Ltd's Other Long-Term Assets amounts to 62.1m CNY.

What is Jiang Zhong Pharmaceutical Co Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
7%

Over the last year, the Other Long-Term Assets growth was -30%. The average annual Other Long-Term Assets growth rates for Jiang Zhong Pharmaceutical Co Ltd have been -15% over the past three years , 9% over the past five years , and 7% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.